Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-23-032753
Filing Date
2023-04-26
Accepted
2023-04-26 14:08:15
Documents
95

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 4 TO FORM S-1 ea177371-posam4_abvcbio.htm   iXBRL POS AM 2285284
2 CONSENT OF WWC, P.C. ea177371ex23-2_abvcbio.htm EX-23.2 5891
8 GRAPHIC fin_001.jpg GRAPHIC 12153
9 GRAPHIC image_001.jpg GRAPHIC 46212
10 GRAPHIC image_002.jpg GRAPHIC 25260
11 GRAPHIC image_003.jpg GRAPHIC 35814
12 GRAPHIC image_004.jpg GRAPHIC 4413
13 GRAPHIC image_005.jpg GRAPHIC 9334
14 GRAPHIC image_006.jpg GRAPHIC 1781
  Complete submission text file 0001213900-23-032753.txt   9138400

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE abvc-20221231.xsd EX-101.SCH 102876
4 XBRL CALCULATION FILE abvc-20221231_cal.xml EX-101.CAL 47256
5 XBRL DEFINITION FILE abvc-20221231_def.xml EX-101.DEF 358036
6 XBRL LABEL FILE abvc-20221231_lab.xml EX-101.LAB 705570
7 XBRL PRESENTATION FILE abvc-20221231_pre.xml EX-101.PRE 376622
89 EXTRACTED XBRL INSTANCE DOCUMENT ea177371-posam4_abvcbio_htm.xml XML 985163
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-250899 | Film No.: 23848799
SIC: 2834 Pharmaceutical Preparations